|
Market Closed -
Japan Exchange
02:30:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 2,447.00 JPY | -0.24% |
|
+0.62% | +41.20% |
| 09-20 | ISB Corporation(TSE:9702) added to S&P Global BMI Index | CI |
| 08-07 | ISB Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Fiscal Period: December | 2016 (JPY) | 2017 (JPY) | 2018 (JPY) | 2019 (JPY) | 2020 (JPY) | 2021 (JPY) | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.39 | 9.41 | 9.95 | 9.26 | 6.99 | |||||
Return on Total Capital | 12.59 | 14.15 | 15.08 | 13.69 | 10.24 | |||||
Return On Equity % | 12.12 | 14.06 | 13.08 | 16.05 | 10.24 | |||||
Return on Common Equity | 12.12 | 14.06 | 13.08 | 16.05 | 10.24 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.05 | 24.02 | 24.08 | 24.27 | 22.92 | |||||
SG&A Margin | 15.18 | 14.79 | 14.54 | 16.02 | 16.48 | |||||
EBITDA Margin % | 9.27 | 9.69 | 9.99 | 8.99 | 7.47 | |||||
EBITA Margin % | 8.87 | 9.24 | 9.57 | 8.25 | 6.45 | |||||
EBIT Margin % | 7.14 | 8.01 | 8.47 | 8.25 | 6.25 | |||||
Income From Continuing Operations Margin % | 4.24 | 4.92 | 4.54 | 5.98 | 3.88 | |||||
Net Income Margin % | 4.24 | 4.92 | 4.54 | 5.98 | 3.88 | |||||
Net Avail. For Common Margin % | 4.24 | 4.92 | 4.54 | 5.98 | 3.88 | |||||
Normalized Net Income Margin | 4.63 | 5.14 | 5.42 | 5.34 | 4.02 | |||||
Levered Free Cash Flow Margin | 5.08 | 6.76 | 6.61 | 3.48 | 1.85 | |||||
Unlevered Free Cash Flow Margin | 5.08 | 6.76 | 6.61 | 3.48 | 1.85 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.88 | 1.88 | 1.88 | 1.8 | 1.79 | |||||
Fixed Assets Turnover | 27.4 | 29.02 | 33.72 | 34.82 | 25.05 | |||||
Receivables Turnover (Average Receivables) | 5.6 | 5.62 | 5.79 | 5.72 | 5.94 | |||||
Inventory Turnover (Average Inventory) | 42.71 | 40.92 | 34.61 | 31.82 | 27.78 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.75 | 2.68 | 2.76 | 2.81 | 2.77 | |||||
Quick Ratio | 2.61 | 2.49 | 2.59 | 2.6 | 2.53 | |||||
Operating Cash Flow to Current Liabilities | 0.35 | 0.37 | 0.34 | 0.32 | 0.29 | |||||
Days Sales Outstanding (Average Receivables) | 65.17 | 64.99 | 63.06 | 64.04 | 61.41 | |||||
Days Outstanding Inventory (Average Inventory) | 8.55 | 8.92 | 10.55 | 11.5 | 13.14 | |||||
Average Days Payable Outstanding | 28.4 | 30.21 | 31.1 | 31.14 | 29.65 | |||||
Cash Conversion Cycle (Average Days) | 45.32 | 43.7 | 42.5 | 44.4 | 44.9 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.26 | 1.12 | 1.02 | 0.89 | 0.83 | |||||
Total Debt / Total Capital | 1.24 | 1.11 | 1 | 0.88 | 0.82 | |||||
LT Debt/Equity | - | - | - | - | - | |||||
Long-Term Debt / Total Capital | - | - | - | - | - | |||||
Total Liabilities / Total Assets | 33.45 | 35.1 | 34.29 | 31.8 | 32.8 | |||||
EBIT / Interest Expense | 1.87K | 2.32K | 2.74K | 2.8K | 2.32K | |||||
EBITDA / Interest Expense | 2.43K | 2.8K | 3.23K | 3.05K | 2.77K | |||||
(EBITDA - Capex) / Interest Expense | 2.28K | 2.69K | 3.12K | 2.68K | 1.87K | |||||
Total Debt / EBITDA | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | |||||
Net Debt / EBITDA | -2.45 | -2.68 | -2.71 | -2.9 | -3.24 | |||||
Total Debt / (EBITDA - Capex) | 0.05 | 0.04 | 0.04 | 0.04 | 0.06 | |||||
Net Debt / (EBITDA - Capex) | -2.61 | -2.79 | -2.81 | -3.3 | -4.79 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 7.13 | 10.61 | 11.87 | 4.84 | 9.03 | |||||
Gross Profit, 1 Yr. Growth % | 7.72 | 10.48 | 12.14 | 5.65 | 2.99 | |||||
EBITDA, 1 Yr. Growth % | 8.98 | 15.62 | 15.29 | -5.6 | -9.37 | |||||
EBITA, 1 Yr. Growth % | 9.58 | 15.21 | 15.86 | -9.62 | -14.79 | |||||
EBIT, 1 Yr. Growth % | 13.75 | 24.01 | 18.28 | 2.08 | -17.32 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 11.67 | 28.2 | 3.44 | 38.04 | -29.38 | |||||
Net Income, 1 Yr. Growth % | 11.67 | 28.2 | 3.44 | 38.04 | -29.38 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.38 | 22.78 | 17.93 | 3.24 | -17.83 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 3.92 | 27.92 | 3.19 | 37.77 | -29.52 | |||||
Accounts Receivable, 1 Yr. Growth % | 11.47 | 9.26 | 7.9 | 4.58 | 5.09 | |||||
Inventory, 1 Yr. Growth % | -40.31 | 108.91 | -4.54 | 32.85 | 22.78 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 7.72 | 1.31 | -8.67 | 12.65 | 86.16 | |||||
Total Assets, 1 Yr. Growth % | 6.34 | 14.6 | 9.3 | 10.07 | 9.14 | |||||
Tangible Book Value, 1 Yr. Growth % | 16.94 | 16.9 | 14.54 | 8.44 | 7.62 | |||||
Common Equity, 1 Yr. Growth % | 9.17 | 11.77 | 10.65 | 14.24 | 7.55 | |||||
Cash From Operations, 1 Yr. Growth % | -21.79 | 32.19 | 0.99 | -3.34 | -7.18 | |||||
Capital Expenditures, 1 Yr. Growth % | 102.74 | -22.3 | -0.87 | 226.32 | 140.59 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -19.9 | 47.15 | 9.51 | -44.79 | -42.21 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -20.02 | 47.12 | 9.51 | -44.78 | -42.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 13.21 | 33.33 | 5 | 28.57 | 1.85 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 7.81 | 8.85 | 11.23 | 8.29 | 6.91 | |||||
Gross Profit, 2 Yr. CAGR % | 10.28 | 9.09 | 11.31 | 8.85 | 4.31 | |||||
EBITDA, 2 Yr. CAGR % | 15.42 | 12.25 | 15.46 | 4.33 | -7.5 | |||||
EBITA, 2 Yr. CAGR % | 17.16 | 12.36 | 15.53 | 2.33 | -12.24 | |||||
EBIT, 2 Yr. CAGR % | 25.15 | 18.77 | 21.11 | 9.88 | -8.13 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 32.42 | 19.65 | 15.16 | 19.5 | -1.26 | |||||
Net Income, 2 Yr. CAGR % | 32.42 | 19.65 | 15.16 | 19.5 | -1.26 | |||||
Normalized Net Income, 2 Yr. CAGR % | 25.74 | 17.99 | 20.33 | 10.34 | -7.89 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 25.57 | 15.3 | 14.89 | 19.23 | -1.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 8.49 | 10.36 | 8.57 | 6.22 | 4.83 | |||||
Inventory, 2 Yr. CAGR % | -24.53 | 11.67 | 41.22 | 12.62 | 27.72 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.82 | 4.47 | -3.81 | 1.43 | 44.81 | |||||
Total Assets, 2 Yr. CAGR % | 8.3 | 10.39 | 11.92 | 9.68 | 9.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 32.94 | 16.92 | 15.71 | 11.45 | 8.03 | |||||
Common Equity, 2 Yr. CAGR % | 19.55 | 10.46 | 11.21 | 12.43 | 10.84 | |||||
Cash From Operations, 2 Yr. CAGR % | 4 | 1.68 | 15.54 | -1.2 | -5.28 | |||||
Capital Expenditures, 2 Yr. CAGR % | 40.48 | 25.51 | -12.24 | 79.86 | 180.19 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -15.7 | 8.56 | 26.94 | -22.25 | -43.52 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -15.84 | 8.48 | 26.93 | -22.24 | -43.5 | |||||
Dividend Per Share, 2 Yr. CAGR % | 25.66 | 22.86 | 18.32 | 16.19 | 14.43 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.49 | 8.74 | 9.85 | 9.06 | 8.54 | |||||
Gross Profit, 3 Yr. CAGR % | 21.37 | 10.35 | 10.1 | 9.39 | 6.86 | |||||
EBITDA, 3 Yr. CAGR % | 27.41 | 15.49 | 13.26 | 7.96 | -0.45 | |||||
EBITA, 3 Yr. CAGR % | 31.53 | 16.5 | 13.51 | 6.45 | -3.73 | |||||
EBIT, 3 Yr. CAGR % | 29.1 | 24.77 | 18.61 | 14.4 | -0.06 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 26.68 | 31 | 13.98 | 22.33 | 0.28 | |||||
Net Income, 3 Yr. CAGR % | 26.68 | 31 | 13.98 | 22.33 | 0.28 | |||||
Normalized Net Income, 3 Yr. CAGR % | 28.42 | 24.75 | 17.97 | 14.34 | 0.01 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 22.27 | 26.35 | 11.11 | 22.06 | 0.06 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.04 | 8.74 | 9.53 | 7.23 | 5.84 | |||||
Inventory, 3 Yr. CAGR % | -17.42 | 5.97 | 5.98 | 38.37 | 15.91 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.88 | 3.64 | -0.11 | 1.39 | 24.19 | |||||
Total Assets, 3 Yr. CAGR % | 12.89 | 10.36 | 10.03 | 11.3 | 9.5 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.66 | 27.36 | 16.12 | 13.24 | 10.16 | |||||
Common Equity, 3 Yr. CAGR % | 15.61 | 16.9 | 10.53 | 12.21 | 10.78 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.05 | 12.66 | 1.45 | 8.87 | -3.24 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.77 | 15.31 | 16.02 | 35.96 | 98.17 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 13.39 | 1.5 | 8.88 | -3.82 | -29.57 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 13.31 | 1.39 | 8.82 | -3.82 | -29.56 | |||||
Dividend Per Share, 3 Yr. CAGR % | 22.05 | 28.16 | 16.59 | 21.64 | 11.2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 14.34 | 11.68 | 13.18 | 8.56 | 8.66 | |||||
Gross Profit, 5 Yr. CAGR % | 28.17 | 17.85 | 17.24 | 9.75 | 7.75 | |||||
EBITDA, 5 Yr. CAGR % | 31.8 | 24.73 | 22.49 | 10.89 | 4.45 | |||||
EBITA, 5 Yr. CAGR % | 45.25 | 29.09 | 24.88 | 10.61 | 2.41 | |||||
EBIT, 5 Yr. CAGR % | 43.91 | 31.27 | 25.85 | 18.59 | 7.09 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 44.7 | 35.9 | 21.94 | 26.27 | 7.62 | |||||
Net Income, 5 Yr. CAGR % | 44.7 | 35.9 | 21.94 | 26.27 | 7.62 | |||||
Normalized Net Income, 5 Yr. CAGR % | 43.04 | 30.64 | 25.12 | 18.77 | 6.85 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 41.65 | 32.98 | 19.26 | 23.45 | 5.9 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.74 | 9.89 | 10.04 | 7.73 | 7.63 | |||||
Inventory, 5 Yr. CAGR % | 4.52 | 2.55 | 2.35 | 8.58 | 14.19 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.69 | 3.96 | 1.89 | 2.75 | 15.89 | |||||
Total Assets, 5 Yr. CAGR % | 12.98 | 12.35 | 12.5 | 10.09 | 9.86 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.52 | 15.14 | 15.68 | 20.74 | 12.81 | |||||
Common Equity, 5 Yr. CAGR % | 11.46 | 12.98 | 13.83 | 15.09 | 10.65 | |||||
Cash From Operations, 5 Yr. CAGR % | 33.39 | 46.03 | 10.99 | 6.9 | -1.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | 26.88 | 20.64 | 1.47 | 37.75 | 65.08 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 71.58 | 79.74 | 18.63 | -8.76 | -16.26 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 71.6 | 77.87 | 18.57 | -8.82 | -16.28 | |||||
Dividend Per Share, 5 Yr. CAGR % | 19.14 | 26.19 | 20.55 | 23.23 | 15.72 |
- Stock Market
- Stocks
- 9702 Stock
- Financials ISB Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















